Illinois Municipal Retirement Fund Sells 404 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Illinois Municipal Retirement Fund cut its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 12.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,842 shares of the medical instruments supplier’s stock after selling 404 shares during the period. Illinois Municipal Retirement Fund’s holdings in Mesa Laboratories were worth $298,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Louisiana State Employees Retirement System bought a new stake in shares of Mesa Laboratories during the fourth quarter valued at about $272,000. SG Americas Securities LLC increased its position in shares of Mesa Laboratories by 23.1% during the third quarter. SG Americas Securities LLC now owns 2,928 shares of the medical instruments supplier’s stock valued at $308,000 after buying an additional 549 shares during the period. Jump Financial LLC increased its position in shares of Mesa Laboratories by 77.4% during the third quarter. Jump Financial LLC now owns 3,293 shares of the medical instruments supplier’s stock valued at $346,000 after buying an additional 1,437 shares during the period. Dark Forest Capital Management LP increased its position in shares of Mesa Laboratories by 107.4% during the third quarter. Dark Forest Capital Management LP now owns 7,480 shares of the medical instruments supplier’s stock valued at $786,000 after buying an additional 3,873 shares during the period. Finally, Motley Fool Asset Management LLC increased its position in shares of Mesa Laboratories by 2.0% during the third quarter. Motley Fool Asset Management LLC now owns 7,931 shares of the medical instruments supplier’s stock valued at $833,000 after buying an additional 154 shares during the period. 90.60% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Evercore ISI upped their price objective on shares of Mesa Laboratories from $124.00 to $130.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th.

Mesa Laboratories Stock Up 3.9 %

MLAB stock opened at $110.18 on Thursday. The company has a current ratio of 2.68, a quick ratio of 1.86 and a debt-to-equity ratio of 0.58. The company’s 50 day moving average is $105.29 and its 200 day moving average is $99.74. The stock has a market cap of $593.87 million, a price-to-earnings ratio of 648.16 and a beta of 0.83. Mesa Laboratories, Inc. has a 1-year low of $82.86 and a 1-year high of $172.80.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings data on Monday, February 5th. The medical instruments supplier reported $1.46 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.01). The company had revenue of $53.47 million during the quarter, compared to the consensus estimate of $54.90 million. Mesa Laboratories had a return on equity of 7.41% and a net margin of 0.45%. Sell-side analysts predict that Mesa Laboratories, Inc. will post 6.15 EPS for the current fiscal year.

Mesa Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Friday, May 31st will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend is Friday, May 31st. Mesa Laboratories’s dividend payout ratio is currently 376.49%.

About Mesa Laboratories

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.